PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
Zhao L, Liu J, Li K, Zhang C, Chen T, Liu Z, Tang Y, Hu X, Shi A, Shu L, Huang S, Lian S, Zhang M, Li H, Sun J, Yu X, Zhang Z, Zhang Z, Xu Y.
Zhao L, et al. Among authors: li h, li k.
Hepatology. 2024 Apr 1;79(4):798-812. doi: 10.1097/HEP.0000000000000552. Epub 2023 Jul 27.
Hepatology. 2024.
PMID: 37505213